Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 211-220 of 408 for center for individualized medicine

Edit search filters
  1. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)

    Rochester, MN

  2. Attitudes and Beliefs About Gene Transfer Therapy in Adults with Cocaine Use Disorder

    Rochester, MN

  3. A Registry To Collect Patient And Family DNA And Information For Anyone Who Has Had Multiplex Testing And Gene Mutation Results

    Rochester, MN

  4. Impact Of Neoadjuvant Chemotherapy On The Peripheral Blood Immune Phenotype In Operable Breast Cancer, The ENHANCE Study

    Rochester, MN

  5. Stewardship, AMR Technology, and Ethics

    Rochester, MN

  6. Accuracy of Patient-Specific Implants and Instrumentation in Total Hip Arthroplasty

    Rochester, MN

  7. Patient Perceptions of the Impact of Unproven Stem Cell Corrections

    Rochester, MN

  8. Development of Novel Mutation Detection Methods for Lung Cancer

    Rochester, MN

  9. Bile Acids, Genetic Control and Ileo-Colonic Mucosal Expression in IBS-D

    Rochester, MN

  10. Plasma Proneurotensin As A Predictive Biomarker For Breast Cancer In Genetically Predisposed Patients

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer